AI tools to improve diagnosis and therapy in neuro-oncology
Pearl Freier, Founder of Cambridge BioPartners, shared a recent article by on X:
“AI tools to improve diagnosis and therapy in neuro-oncology are increasing and The Lancet Oncology review provides an assessment of the field with focus on Artificial Intelligence for Response Assessment in Neuro Oncology.
AI models of key genomic markers and predictive AI models of response before and after therapy.”
Authors: Spyridon Bakas, Janine M Lupo, Evan Calabrese, Christos Davatzikos, Wenya Linda Bi, Marwa Ismail, Hamed Akbari, Philipp Lohmann, Thomas C Booth, Benedikt Wiestler, Hugo J W L Aerts, Ghulam Rasool, Joerg C Tonn, Martha Nowosielski, Rajan Jain, Rivka R Colen, Sarthak Pati, Ujjwal Baid, Philipp Vollmuth, David Macdonald, Michael A Vogelbaum, Susan M Chang, Raymond Y Huang and Norbert Galldiks
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023